Iannello, Andrea
Deaglio, Silvia
Vaisitti, Tiziana
Funding for this research was provided by:
Associazione Italiana per la Ricerca sul Cancro (MFAG-23107, IG-23095)
Ministero della Salute (GR-2016-02364298)
Ministero dell’Istruzione, dell’Università e della Ricerca (D15D18000410001)
Article History
Accepted: 23 February 2022
First Online: 16 March 2022
Change Date: 15 July 2022
Change Type: Update
Change Details: The original version of this paper was updated to present the missing Open Access funding note.
Declarations
:
: Andrea Iannello declares that he has no conflict of interest. Silvia Deaglio declares that she has received research funds from AstraZeneca, VelosBio Inc., Heildeberg Pharma. Tiziana Vaisitti declares that she has received research funds from AstraZeneca.
: This article does not contain any studies with human or animal subjects performed by any of the authors.